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Objectives: To determine cutoff values for body mass index (BMI), waist circumference 
(WC), waist-to-hip ratio (WHR), and waist-to-height ratio (WHtR) as indicators of metabolic 
abnormalities in the adult Jordanian population.
Methods: A structured questionnaire was administered to collect relevant information. Anthro-
pometric measurements and biochemical measurements were carried out. Receiver-operating 
characteristic curve analyses were used to examine the overall discriminatory power of the four 
anthropometric indices.
Results: WC cutoff values varied from 88.5 to 91.8 cm in men and from 84.5 to 88.5 cm 
in women. The BMI cutoff values varied from 26.2 to 27.2 kg/m2 in men and from 27.2 to 
30.0 kg/m2 in women. The WHR cutoff values varied from 0.88 to 0.90 in men and from 80.0 to 
0.83 in women. The WHtR cutoff values varied from 0.50 to 0.51 in men and women. Of all 
anthropometric indices, WHtR had the strongest association with each metabolic abnormality 
in men and women.
Conclusion: BMI, WC, WHR, and WHtR were found to be associated with cardiovascular 
disease risk factors, with WHtR being the better predictor. We recommend that health care profes-
sionals use WHtR, with a cutoff value of 0.5 for screening and counseling Jordanian people.
Keywords: anthropometric indices, metabolic abnormalities, receiver-operating characteristic 
curve, cutoff values, Jordan
Introduction
Anthropometric indices, including body mass index (BMI), waist circumference (WC), 
waist-to-hip ratio (WHR), and waist-to-height ratio (WHtR), are all useful for providing 
important information on cardiovascular disease (CVD) risk, and have been shown to be 
associated with CVD risk factors, including hypertension, dyslipidemia, and diabetes.1–3 
Body mass index (BMI) is a simple measure of body size and is the most widely used 
method to estimate the prevalence of obesity in a population. Nevertheless, it is a crude 
index that does not take into account the distribution of body fat. On the other hand, 
WC, WHR, and WHtR are used as a surrogate for body fat centralization.4,5
The best index of obesity that is predictive for CVD risk remains controversial. 
Some studies have found that total body fat or BMI, rather than distribution of body 
fat, is the stronger predictor of metabolic risk.6,7 Other studies have reported that body 
fat distribution is a more powerful predictor than BMI for CVD risk factors, diseases, 
and mortality.8–10 Abdominal fat accumulation, as measured by WC or WHR, has 
been shown to be associated with metabolic and CVD risk, type 2 diabetes mellitus, 
hypertension, coronary artery disease, and stroke,8,9,11–13 and a stronger association was Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
396
Khader et al
found with abdominal adiposity than with overall adiposity 
as measured by BMI.14–17
WC is a good simple anthropometric index of abdominal 
visceral adipose tissue,5 and is increasingly being accepted 
as the best anthropometric indicator of metabolic and 
cardiovascular risk.3,19,20 Because the WC measurement 
has been criticized for not taking into account differ-
ences in body height, the WHtR value is suggested as an 
alternative.1,2,21
The anthropometric-metabolic risk relationship is 
influenced by age, gender, and ethnic differences. The 
predictive power of some anthropometric indices is popu-
lation-dependent22 and is likely to be different in different 
ethnic groups.23–27 Because populations may differ in the 
level of risk associated with a particular anthropometric 
measure, establishing gender- and ethnicity-specific cutoffs 
is necessary and should be based on their relationship with 
obesity-related CVD risk factors. The International Diabe-
tes Federation has suggested a redefinition of the metabolic 
syndrome using WCs adapted for different ethnic groups,28 
and recommends the use of European cutoff values for WC 
measurements in people from Middle East Arab populations 
until more ethnic-specific data are available. In this study, we 
aimed to determine cutoff values of BMI, WC, WHR, and 
WHtR as indicators of metabolic abnormalities in the adult 
Jordanian population and determine their associations with 
the presence of metabolic abnormalities.
Materials and methods
Sampling
A national population-based household sample was selected 
from the 12 governorates of Jordan. A complex multistage 
sampling technique was used to select the households, tak-
ing into consideration the geographic distribution of the 
population as well as urban-rural residence. Because the 
population is covered by an extensive network of health 
centers and because the study procedures have to take place 
in a medical setting, the selection of households was health 
center-oriented. The health director in each governorate was 
contacted and asked to identify at least two health centers 
in which to conduct the study procedures. He was asked 
to select the health centers so that urban and rural areas in 
each governorate were represented and the selected centers 
had enough space to host the study team, participants, and 
equipment. A total of 31 health centers were identified, and 
people served by these centers were targeted. A systematic 
sample of households was selected from the population 
served by the selected health centers. The number of selected 
households was approximately proportional to the popula-
tion in each region.
In each selected area, one day before data collection, 
two-membered teams (a male and a female each) visited the 
selected households, explained the purpose of the study, and 
invited all members aged older than seven years to attend the 
health centers on the day after an overnight fast. Subjects on 
regular medications were asked not to take their medications 
early on that day and to bring all their medications with them 
to the survey site. The present report deals exclusively with 
4590 adults aged over 18 years who responded and agreed 
to participate in this study.
Data collection
All field work was carried out between July 1st and 
November 30, 2009. Participants attended the health centers 
in the morning (8–11 am), with a minimum fasting time 
of 10 hours. A pilot-tested structured questionnaire was 
prepared and administered by trained interviewers to collect 
the relevant information necessary to answer the current 
research question and other selected research questions   
that will be addressed in future publications. The question-
naire sought information on demographics, medical history, 
and medication use.
Measurements and laboratory analysis
Anthropometric measurements, including weight, height, 
hip, and WC were measured with the subjects wearing light 
clothing and no shoes according to the World Health Organi-
zation report.29 WC was measured to the nearest centimeter 
using a nonstretchable tailors’ measuring tape at the midpoint 
between the bottom of the rib cage and above the top of the 
iliac crest during minimal respiration. Hip circumference was 
measured at the widest part of the body below the waist. Waist 
and hip circumferences were measured using a circumference 
measuring tape (Seca 200, Hamburg, Germany). BMI was 
calculated as the ratio of weight in kilograms to the square 
of height in meters. Readings of systolic and diastolic blood 
pressure were taken with the subject seated and the arm at 
heart level, after at least five minutes of rest, using a standard-
ized mercury sphygmomanometer.30
For laboratory analysis and all biochemical measure-
ments, two sets of fasting blood samples were drawn from a 
cannula inserted in the antecubital vein and put into sodium 
fluoride potassium oxalate tubes for glucose and into lithium 
heparin vacuum tubes for lipids. Samples were centrifuged 
at 3000 rpm for 10 minutes within one hour at the survey 
site, and plasma was transferred to separate labeled tubes and Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 submit your manuscript | www.dovepress.com
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transferred immediately in cold boxes filled with ice to the 
Central Laboratory of the National Center for Diabetes and 
Endocrinology. All biochemical measurements were carried 
out by the same team of laboratory technicians and using the 
same method throughout the study period.
Lipid parameters, ie, total cholesterol, high-density 
lipoprotein (HDL), low-density lipoprotein (LDL), and 
triglyceride (TG), and glucose were analyzed for all samples 
using enzymatic assays. Glucose levels were determined 
using the enzymatic reference method with hexokinase.31 
TG values were obtained using COBAS Integra 700 (Roche 
Diagnostics Ltd, Indianapolis, IN) with the cassette COBAS 
Integra TG (Roche Diagnostics Ltd) using an enzymatic 
colorimetric method with glycerol phosphate oxidase and 
4-aminophenazone.32 Total cholesterol was analyzed using an 
enzymatic colorimetric method with COBAS Integra Choles-
terol Gen.2 (Roche Diagnostics Ltd). HDL and LDL values 
were obtained on COBAS Integra 700 using a homogeneous 
enzymatic colorimetric assay.33,34 The assays were conducted 
according to the manufacturer’s instructions.
Definition of variables
Metabolic abnormalities were defined according to the Inter-
national Diabetes Federation definition,28 as follows: elevated 
TG level $ 150 mg/dL (1.7 mmol/L), or specific treatment 
for this lipid abnormality; low HDL cholesterol , 40 mg/dL 
(1.03 mmol/L) in males and ,50 mg/dL (1.29 mmol/L) in 
females, or specific treatment for this lipid abnormality; high 
blood pressure, ie, systolic blood pressure $130 mmHg or 
diastolic blood pressure $ 85 mmHg, or treatment of previ-
ously diagnosed hypertension; high fasting plasma glu-
cose $100 mg/dL (5.6 mmol/L), or previously diagnosed 
type 2 diabetes.
Statistical analysis
Data were analyzed using the Statistical Package for Social 
Sciences software (version 15; SPSS Inc., Chicago, IL). 
The distributions of continuous anthropometric and clinical 
variables were checked by plotting histograms and tested 
using the Shapiro–Wilk W test. The assumption of normal-
ity was met for all studied variables. Means and standard 
deviations were used to describe continuous variables. The 
differences in anthropometric and clinical characteristics 
between men and women were analyzed using the Student’s 
t-test. The data analysis was performed in men and women 
separately. Receiver-operating characteristic (ROC) curve 
analyses35 were used to examine the overall discrimina-
tory power, sensitivity and specificity, and corresponding 
cutoff points of each of the four anthropometric indices for 
each metabolic abnormality. The overall performance of 
each anthropometric test for detecting individual metabolic 
abnormalities was assessed by computing the area under the 
curve (AUC). For each metabolic abnormality, the AUCs 
for all anthropometric indices were compared and tested 
for significant differences using MedCalc version 11.3. 
  (MedCalc Software, Mariakerke, Belgium). The best cutoff 
points for each anthropometric index were determined at the 
point on the curve where the sum of sensitivity and specificity 
was highest. Age-adjusted partial correlation analyses were 
performed to quantify the independent associations between 
anthropometric indices. Each anthropometric index was 
dichotomized for each metabolic abnormality based on the 
cutoff values established in this study. Multivariate logistic 
regression analyses were performed to evaluate the asso-
ciations between the anthropometric indices and individual 
metabolic abnormalities after adjusting for other variables 
including age, marital status, income, smoking, and physi-
cal activity. Backward stepwise logistic regression analysis 
was performed using metabolic abnormalities as dependent 
variables. Because the indices were intercorrelated, only 
one out of the four indices was introduced into the logistic 
regression equation at each analysis. A P value of less than 
0.05 was considered statistically significant.
Results
A total of 4590 subjects (1128 men and 3462 women) aged 
over 18 years, with a mean age of 41.8 (13.4) years were 
included in this study. Table 1 shows their anthropometric 
and clinical characteristics according to gender. There were 
significant differences in anthropometric and clinical param-
eters between men and women. Men had significantly higher 
mean weight, height, WC, WHR, WHtR, systolic blood 
pressure, diastolic blood pressure, fasting blood glucose, and 
TG levels than women. Other parameters were significantly 
higher for women compared with those for men. Men had 
significantly higher prevalence rates of high fasting blood 
glucose (34.4% versus 23.6%), high blood pressure (52.9% 
versus 36.6%), elevated TG (62.8% versus 44.1%), and low 
HDL (70.3% versus 64.2%) than women (see Figure 1). The 
age- and gender-adjusted rates for all metabolic abnormalities 
were higher for those living in urban areas compared with 
those living in rural areas.
According to age-adjusted partial correlations among the 
anthropometric indices, BMI, WC, and WHtR were moder-
ately to strongly intercorrelated in men and women. BMI and 
WHR were weakly correlated, especially among women.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 submit your manuscript | www.dovepress.com
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The calculated AUCs of anthropometric indices for 
distinguishing subjects with metabolic abnormalities are 
summarized in Table 2. For men, there was no significant 
difference in anthropometric indices to discriminate between 
subjects based on high blood pressure or low HDL. In regard 
to elevated TG level, WC and WHtR performed significantly 
better than BMI. All other indices performed better than BMI 
for detection of high fasting blood glucose. For women, all 
other indices performed better than WHR to detect high 
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Figure 1 Prevalence rates of metabolic abnormalities according to the International Diabetes Federation definition for men and women.
Table  1  Anthropometric  and  clinical  characteristics  of  4590 
Jordanian adults (1128 men and 3462 women) aged over 18 years 
according to gender
Variable Mean (SD) P value
Male  Female
Age (year) 45.3 (14.2) 40.7 (12.9) ,0.005
Weight (kg) 82.4 (14.8) 73.7 (15.2) ,0.005
height (cm) 169.2 (6.8) 156.3 (6.2) ,0.005
Waist circumference (cm) 93.5 (12.7) 85.3 (14.6) ,0.005
hip circumference (cm) 103.4 (10.0) 107.6 (12.2) ,0.005
Body mass index (kg/m2) 28.8 (5.0) 30.2 (6.2) ,0.005
Waist–hip ratio  0.90 (0.08) 0.79 (0.11) ,0.005
Waist–height ratio  0.55 (0.08) 0.54 (0.10) 0.043
Systolic blood pressure 
(mmhg)
124.9 (17.2) 121.3 (17.1) ,0.005
Diastolic blood  
pressure (mmhg)
 81.0 (10.9) 78.3 (10.0) ,0.005
Total cholesterol (mg/dL) 199.4 (44.3) 204.0 (45.6) ,0.005
hDL cholesterol (mg/dL) 36.1 (11.1) 46.5 (13.3) 0.003
LDL cholesterol (mg/dL) 116.0 (36.9) 119.3 (37.6) 0.001
Fasting blood glucose  
(mg/dL)
110.8 (59.0) 99.6 (46.8) ,0.005
Triglycerides (mg/dL) 207.7 (137.8) 164.1 (115.9) ,0.005
Abbreviations: hDL, high-density lipoprotein; LDL, low-density lipoprotein; SD, 
standard deviation.
blood pressure and low HDL. BMI performed the worst to 
detect high fasting blood glucose. WHtR performed the best 
for detection of elevated TG levels.
The anthropometric cutoff values for detecting each 
metabolic abnormality for men and women are shown in 
Table 3. The WC cutoff values varied according to metabolic 
abnormalities from 88.5 to 91.8 cm in men and from 84.5 to 
88.5 cm in women. The BMI cutoff values varied from 26.2 
to 27.2 kg/m2 in men and from 27.2 to 30.0 kg/m2 in women. 
The WHR cutoff values varied from 0.88 to 0.90 in men and 
from 80.0 to 0.83 in women. The WHtR cutoff values varied 
from 0.50 to 0.51 in men and women.
Anthropometric indices were tested separately in logis-
tic regression models as main predictor variables for each 
outcome variable (Table 4). Significant associations were 
observed between each anthropometric parameter and all 
metabolic abnormalities. The strength of the association in 
the regression analysis varied according to gender, anthro-
pometric index, and metabolic abnormality. Of all anthro-
pometric indices, WHtR had the strongest association with 
each metabolic abnormality in men and women, being the 
strongest for elevated TG in men and high fasting blood 
glucose in women. For all logistic regression analyses, there 
were no significant interactions between anthropometric 
measures and age.
Discussion
Based on the AUC, the ability of anthropometric measures 
to identify subjects with metabolic abnormalities varied 
according to gender and according to the studied metabolic 
abnormality in men and women. The finding that none of Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 submit your manuscript | www.dovepress.com
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Table 2 calculated areas under the rOc curves and their 95% ci of anthropometric indices for detecting metabolic abnormalities
High blood pressure High fasting blood glucose Elevated triacylglycerol Low HDL
  AUC (95% CI) AUC (95% CI) AUC (95% CI) AUC (95% CI)
Males
BMi 0.662 (0.630, 0.693) 0.631 (0.587, 0.676) b 0.638 (0.604, 0.673) b 0.615 (0.578, 0.652)
Wc 0.662 (0.631, 0.694) 0.690 (0.647, 0.733) a 0.666 (0.633, 0.699) a 0.621 (0.584, 0.658)
Whr 0.646 (0.614, 0.678) 0.720 (0.678, 0.761) a 0.655 (0.622, 0.688)  0.636 (0.600, 0.672)
Whtr 0.664 (0.633, 0.696) 0.702 (0.660, 0.744) a 0.662 (0.628, 0.695) a 0.610 (0.573, 0.647)
Females        
BMi 0.731 (0.713, 0.748) a 0.683 (0.656, 0.711) b 0.695 (0.677, 0.713) 0.647 (0.627, 0.666) a
Wc 0.722 (0.702, 0.741) a 0.715 (0.686, 0.744) a 0.692 (0.673, 0.710) b 0.640 (0.620, 0.660) a
Whr 0.675 (0.655, 0.695) b 0.731 (0.700, 0.761) a 0.684 (0.665, 0.703) b 0.622 (0.602, 0.642) b
Whtr 0.725 (0.706, 0.744) a 0.723 (0.694, 0.751) a 0.701 (0.683, 0.719) a 0.638 (0.618, 0.657) a
Notes: Within each column, anthropometric parameters with letter “a” are significantly superior to other parameters with letter “b”.
Abbreviations: BMI, body mass index; CI, confidence interval; AUC, area under concentration time curve; HDL, high-density lipoprotein; ROC, receiver-operating 
characteristic curve; Wc, waist circumference; Whr, waist-to-hip ratio; Whtr, waist-to-height ratio.
Table 3 Anthropometric parameters cutoff values for detecting high fasting blood glucose, high blood pressure, elevated triacylglycerol 
level, and low hDL for men and women
Index High blood pressure High fasting blood glucose Elevated triacylglycerol Low HDL
  Cutoff  Sens  Spec  Cutoff Sens Spec  Cutoff Sens  Spec  Cutoff  Sens Spec 
Males
BMi 27.2 0.765 0.492 27.1 0.819 0.404 26.2 0.805 0.442 26.2 0.768 0.434
Wc 90.2 0.728 0.524 91.8 0.763 0.522 89.6 0.75 0.516 88.5 0.727 0.472
Whr 0.88 0.75 0.51 0.90 0.751 0.596 0.89 0.702 0.558 0.88 0.673 0.551
Whtr 0.50 0.752 0.52 0.50 0.802 0.512 0.50 0.783 0.481 0.51 0.75 0.443
Females
BMi 30.0 0.726 0.626 29.1 0.786 0.489 28.0 0.8 0.508 27.2 0.746 0.47
Wc 88.5 0.653 0.719 87.5 0.743 0.627 84.5 0.71 0.612 84.5 0.6 0.619
Whr 0.82 0.543 0.745 0.83 0.655 0.75 0.8 0.656 0.648 0.8 0.515 0.686
Whtr 0.51 0.621 0.76 0.51 0.778 0.611 0.50 0.714 0.626 0.50 0.492 0.724
Abbreviations: HDL, high-density lipoprotein; Sens, sensitivity; Spec, specificity; BMI, body mass index; WC, waist circumference; WHR, waist-to-hip ratio; WHtR, waist-
to-height ratio. 
the anthropometric measures appeared better than the others 
for detection of all or at least most of the studied metabolic 
abnormalities may be explained by the moderate-to-strong 
correlations between these anthropometric measures. When 
we compared anthropometric measures in regression analy-
sis, the strength of the association varied according to gender, 
anthropometric index, and metabolic abnormality. In our 
study, women had higher BMI and lower WC than men. 
This finding is expected in our population because men are 
taller than women. Furthermore, BMI calculation is solely 
dependent on the net weight and height of the individual, and 
does not consider the distribution of muscle and bone mass. 
BMI also does not differentiate between body fat and muscle 
mass. This may result in misleading information with regard 
to the amount of fat in an individual. Of all anthropomet-
ric indices, WHtR had the strongest association with each 
metabolic abnormality in men and women. There were no 
significant interactions between anthropometric measures and 
age, suggesting that the associations did not vary substantially 
as a function of age and that the results can be generalized 
to Jordanian adults older than 18 years.
Previous studies have reached different conclusions about 
which anthropometric index is the best for detecting the 
risk of metabolic abnormalities. This could be related to the 
fact that the predictive power of each anthropometric index 
depends on the studied population22 and ethnicity.4
Studies in some populations, including in Japan, Canada, 
and Australia,36–41 have reported WHR to be a better indicator 
of CVD risk than BMI. WHR has been shown to be a better 
predictor of coronary heart disease than WC and BMI in a 
prospective study of Finnish men aged 42–60 years.42 Further-
more, WHR has been shown to predict CVD risk factors more 
accurately than BMI, but not WC, in a study of adult Canadian 
men.43 WHR could provide useful clinical information to iden-
tify subjects with CVD risk factors because it reflects most of 
the lifestyle-related risk factors of an individual.44Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 submit your manuscript | www.dovepress.com
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While some studies have shown WHtR to be a better 
predictor of CVD risk factors,1–3,26,35 other studies showed 
that WC is a better predictor of CVD risk factors.5,16 Studies 
in the US have reported that WC is a better predictor than 
WHR.17,23 On the other hand, some studies have reported that 
total fat and abdominal fat distribution play a similar role 
in cardiovascular disease,46,47 and other studies have found 
that total fat, rather than its distribution, is a more significant 
predictor of metabolic risk.6,7
The discrepancy in the findings of different studies may 
be explained by differences in study populations and ethnic 
groups. Furthermore, studies differed in the site of WC 
measurement. It has been reported that the ability of WC to 
predict CVD risk factors differs according to the site of waist 
measurement. In our study, we measured WC according to 
the World Health Organization recommendation, ie, at the 
midpoint between the lower border of the rib cage and the 
iliac crest.
Our results indicated that ranges of cutoff points for each 
of these anthropometric indices may be considered. Cutoff 
points were dependent on gender and metabolic abnormality. 
Lower cutoff points of BMI and higher cutoff points of WC 
and WHR were more appropriate for men. Cutoff points for 
WHtR in men were similar to those for women.
A number of different thresholds for anthropometric 
indices were suggested. The World Health Organization 
criteria (1999) defined central obesity as a WHR . 0.90 in 
males and . 0.85 in females, or BMI . 30 kg/m2.48 Accord-
ing to World Health Organization recommendations, the 
BMI threshold for increasing disease risk in Caucasian 
populations is 25 kg/m2 for both men and women, and 
this value was suggested to be 23 kg/m2 in Asian men 
and women. The US National Cholesterol Education Pro-
gram Adult Treatment Panel III (NCEP-ATP III) defined 
central obesity as WC $ 102 cm in males and $88 cm 
in females.49 The 2005 International Diabetes Federation 
consensus definition of the metabolic syndrome used 
ethnic-specific cutpoints for waist circumference.50 A WC 
cutoff of 80–85 cm for men and 75–80 cm for women of 
Korean or Asian–Pacific background was suggested.3,51 In 
other studies,2,52 a cutoff value of 0.5 for WHtR has been 
proposed as a boundary value.
For BMI, cutoff values varied from 26.2 to 27.2 kg/m2 
in men and from 27.2 to 30.0 kg/m2 in women. The global 
standard of a BMI of 25 for measurement of overweight for 
both genders falls below these ranges. Values of WC fall into 
a wider range (from 88.5 to 91.8 cm in men and from 84.5 to 
88.5 cm in women). For men, the upper limit in the range of 
WC for Jordanians is lower than the cutoff values defined by 
the NCEP-ATP III (102 cm) and the International Diabetes 
Federation 2005 recommendation (94 cm for European men). 
The International Diabetes Federation cutoff value defined 
for Asian men (90 cm) falls within the range of WC for 
Jordanian men. For women, the WC cutoff point of 88 cm 
is close to our upper limit of 88.5 cm. The cutoff values of 
WHR for men and women (from 0.88 to 0.90 in men and 
from 80.0 to 0.83 in women) were close to those defined by 
World Health Organization criteria. Furthermore, the cutoff 
values of WHtR (0.5 to 0.51 in men and women) were close 
to those defined by others.2,52
The finding that WC cutoff limits for the Jordanian 
population are lower than those for the Western population 
might be explained by ethnic differences in body composi-
tion and by the fact that race/ethnic groups often differ in 
Table 4 relationship between the four anthropometric indices with metabolic abnormalities in multivariate analysis
Index High blood pressure High fasting blood glucose Elevated triacylglycerol Low HDL
OR* 95% CI OR* 95% CI OR* 95% CI OR* 95% CI
BMi
  Male 2.32 (1.76, 3.06) 1.80 (1.15, 2.82)  2.98 (2.22, 3.99) 2.42 (1.79, 3.26)
  Female 2.63 (2.21, 3.12) 2.11 (1.58, 2.80) 2.51 (2.13, 2.96) 2.00 (1.71, 2.38)
Wc
  Male 2.27 (1.73, 2.99) 2.28 (1.51, 3.46) 2.96 (2.22, 3.93) 2.23 (1.66, 3.00)
  Female 2.48 (2.08, 2.96) 2.59 (1.97, 3.41) 2.30 (1.94, 2.72) 1.98 (1.67, 2.34)
Whr
  Male 2.02 (1.51, 2.69) 2.39 (1.56, 3.64) 2.72 (2.03, 3.64) 2.25 (1.66, 3.06)
  Female 1.62 (1.36, 0.94) 2.31 (1.56, 3.48) 2.12 (1.80, 2.50) 1.83 (1.54, 2.16)
Whtr
  Male 2.40 (1.80, 3.21) 2.41 (1.70, 3.96) 3.13 (2.31, 4.22) 2.48 (1.83, 3.43)
  Female 2.49 (2.13, 2.99) 2.74 (2.05, 3.66) 2.53 (2.13, 3.00) 2.12 (1.81, 2.51)
Notes: *Adjusted for age, marital status, income, smoking, and physical activity.
Abbreviations: HDL, high-density lipoprotein; OR, odds ratio; Sens, sensitivity; Spec, specificity; BMI, body mass index; WC, waist circumference; WHR, waist-to-hip ratio; 
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  socioeconomic status, cultural factors, diet, physical activity 
levels, and lifestyle. The choice of which to use could depend 
on other factors. In Jordan, one should consider that mea-
suring hip circumference in community settings and in the 
clinic situation is difficult for cultural reasons. Furthermore, 
inaccurate measurements are expected when undertaken in 
fully clothed subjects.
The main limitation of this study was the use of cross-
sectional data to compare the ability of anthropometric 
indices to detect CVD risk factors. Prospective studies are 
needed to provide stronger evidence on the predictive power 
of anthropometric measures. One of the strengths of this study 
is that we used a representative sample of Jordanian adults 
which enhances the validity of our findings.
In conclusion, BMI, WC, WHR, and WHtR were found 
to be associated with CVD risk factors, with WHtR being the 
better predictor. We recommend that health care professionals 
in Jordan use WHtR with a cutoff value of 0.5 for screening 
and counseling people who face higher metabolic risks during 
physical examinations for many reasons: the value of 0.5 offers 
a simple but effective index for identifying metabolic abnor-
malities, in that a single rule of “keeping WC below half of 
height” may be applied by health professionals to both men and 
women; closer agreement of values between men and women; 
comparing AUC for anthropometric indices with metabolic 
abnormalities, WHtR was either similar to or better than other 
anthropometric indices to detect metabolic abnormalities; in 
logistic regression, WHtR had the strongest association with all 
metabolic abnormalities in both genders; height is a component 
of this index and this is important because height may influence 
the observation of fat accumulation and/or distribution; and 
several reports have indicated that WHtR corresponds better 
with metabolic risk than other indices.
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